M L Blute

PSA doubling time as a predictor of clinical progression after biochemical failure following radical prostatectomy for prostate cancer.

E. Bergstralh, M. Blute, H. Zincke, 2001, Mayo Clinic proceedings.

Matched comparison of radical nephrectomy vs nephron-sparing surgery in patients with unilateral renal cell carcinoma and a normal contralateral kidney.

A. Weaver, M. Blute, H. Zincke, 2000, Mayo Clinic proceedings.

Risk factors for progression in patients with prostate cancer treated with radical prostatectomy.

M. Blute, H. Zincke, M L Blute, 1996, Seminars in urologic oncology.

Analysis of risk factors for progression in patients with pathologically confined prostate cancers after radical retropubic prostatectomy.

D. Bostwick, E. Bergstralh, H. Zincke, 1996, The Journal of urology.

Use of Gleason score, prostate specific antigen, seminal vesicle and margin status to predict biochemical failure after radical prostatectomy.

E. Bergstralh, M. Blute, H. Zincke, 2001, The Journal of urology.

Radiotherapy for isolated serum prostate specific antigen elevation after prostatectomy for prostate cancer.

D W Hillman, J. Cheville, M. Blute, 2000, The Journal of urology.

Pathologic classification of prostate carcinoma

D. Bostwick, E. Bergstralh, M. Blute, 1998, Cancer.